MEB Receives 86 Millions In Swedish Grants

Congratulations to the researchers at the Department of Medical Epidemiology and Biostatistics (MEB) who received a total of nearly 86 million SEK from the Swedish funding agencies (FORTE, the Swedish Research Council, the Swedish Cancer Society and the Erling-Persson Foundation)!

Project grants from the Swedish Cancer Society

Hans-Olov Adami

Project title: Microbiome, infection, inflammation and cancer risk.

Amount granted for 2025-2026: SEK 1 600 000

Mark Clements

Project title: Long-term effectiveness and costeffectiveness of prostate cancer testing in Sweden

Amount granted for 2025-2027: SEK 4 500 000

Martin Eklund

Project title: Reduced prostate cancer mortality by improved prognostication and treatment selection

Amount granted for 2025-2027: SEK 4 500 000

Marike Gabrielson

Project title: Compliance and response to tamoxifen therapy in breast cancer – A project in precision medicine and individualised therapy

Amount granted for 2025-2027: SEK 3 000 000

Henrik Grönberg

Project title: ProBio: An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer

Amount granted for 2025-2027: SEK 6 750 000

Maria Hedelin

Project title: Diet during radiation therapy to improve long-term intestinal health among cancer survivors – a placebo-controlled randomized trial (FIDURA)

Amount granted for 2025-2027: SEK 3 000 000

Sara Hägg

Project title: Organ-specific biological aging and risk of different cancers

Amount granted for 2025-2026: SEK 1 600 000

Bojing Liu

Project title: AI-driven Precision Medicine: A Multi-modal Approach to Enhance Cancer Prognosis and Treatment Personalization

Amount granted for 2025-2027: SEK 3 000 000

Anna Plym

Project title: Identifying cancer prevention strategies for men at increased genetic risk for prostate cancer

Amount granted for 2025-2027: SEK 3 000 000

Clinical treatment study grants from the Swedish Cancer Society

Jana de Boniface

Project title: Physical exercise during neoadjuvant chemotherapy for breast cancer as a means to increase pathological complete response rates: the randomized Neo-ACT trial

Amount granted for 2025-2029: SEK 12 000 000

Marike Gabrielson

Project title: The POWER trial: A randomised open label phase 3 clinical trial on Personalised dose Optimization With adjuvant tamoxifen therapy in breast cancER

Amount granted for 2025-2029: SEK 9 000 000

Tobias Nordström

Project title: A randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with nonmetastatic high-risk prostate cancer (SPCG 19)

Amount granted for 2025-2027: SEK 5 000 000 SEK

FORTE project grants

Isabell Brikell

Project title: Why are psychiatric diagnoses and medication increasing among children and adolescents? An investigation of contributing factors in a nationally representative study of 34,000 young people over 20 years.

Amount granted for 2025-2027: SEK 4 998 000

Shuyang Yao

Project title: Specifying the relationship between substance abuse and schizophrenia, focusing on adolescents and young adults.

Amount granted for 2025-2027: SEK 4 997 000

Grants from the Swedish Research Council

Cynthia Bulik

Project grant

Project title: Defining the role of metabolic, immune, and neurotrophic markers in the etiology of eating disorders through analysis of PKU samples.

Amount granted for 2025-2027: SEK 3 000 000

Zheng Chang

Consolidator grant

Project title: Personalized medication treatment for ADHD (Attention Deficit Hyperactivity Disorder)

Amount granted for 2025-2029: SEK 10 000 000

Grants from the Erling-Perssons Foundation

Kamila Czene

Project title: Enhanced detection of interval breast cancer during screening by combining molecular and imaging-based markers.

Amount granted for 2025-2027: SEK 6 000 000

/Public Release. View in full here.